ميمپارا

Država: Izrael

Jezik: arapski

Izvor: Ministry of Health

Aktivni sastojci:

CINACALCET HYDROCHLORIDE 90 MG

Dostupno od:

AMGEN EUROPE B.V.

ATC koda:

H05BX01

Farmaceutski oblik:

FILM COATED TABLETS

Administracija rute:

PER OS

Proizveden od:

AMGEN EUROPE B.V., NETHERLANDS

Terapijska grupa:

CINACALCET

Terapijske indikacije:

Treatment of secondary hyperparathyrodism (HPT) in patients with end-dtage renal disease (ESRD) on maintenance dialysis therapy. Mimpara may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma.

Datum autorizacije:

2012-10-01